Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samrat PharmachemBOM:530125 -0.04%63 Dividend Yield % is 0.40% as of Jul. 30, 2026, which is 48% above its 10-year median of 0.27. GuruFocus rates BOM:530125 with a GF Score™ of 63/100 and a GF Value™ of ₹362.79 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,059 Chemicals companies, Samrat Pharmachem ranks worse than 85.55% on this metric.
As of today (2026-07-30), the Trailing Annual Dividend Yield of Samrat Pharmachem is 0.40%.
The historical rank and industry rank for Samrat Pharmachem's Dividend Yield % or its related term are showing as below:
BOM:530125'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.09 Med: 0.27 Max: 0.51
Current: 0.4
During the past 13 years, the highest Dividend Yield of Samrat Pharmachem was 0.51%. The lowest was 0.09%. And the median was 0.27%.
BOM:530125's Dividend Yield % is ranked worse than 85.55% of 1059
companies
in the Chemicals industry
Industry Median: 1.62
vs BOM:530125: 0.40
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Samrat Pharmachem Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Samrat Pharmachem's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Samrat Pharmachem's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samrat Pharmachem Dividend Yield % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Samrat Pharmachem's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Samrat Pharmachem's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Samrat Pharmachem Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 1.000000
2025-09-18
2025-09-19
2025-10-16
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Samrat Pharmachem's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samrat Pharmachem (BOM:530125) has a Dividend Yield % of 0.40% as of Jul. 30, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Samrat Pharmachem and its competitors. This is 48% above median its historical median of 0.27. Over the past decade, Samrat Pharmachem's Dividend Yield % has ranged from 0.09 to 0.51. According to the industry distribution chart, Samrat Pharmachem ranks #906 out of 1059 companies in the Chemicals industry, placing it in the top 85.6%.
Is Samrat Pharmachem's Dividend Yield % too high?
Samrat Pharmachem's current Dividend Yield % of 0.40% is 48% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.51. The Chemicals industry median Dividend Yield % is 1.62. Samrat Pharmachem's value of 0.40% is 75.3% below this industry median. Based on the distribution chart, Samrat Pharmachem ranks #906 out of 1059 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Samrat Pharmachem has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's Dividend Yield % compare to DOW?
According to the Chemicals industry distribution chart, Samrat Pharmachem ranks #906 out of 1059 companies for Dividend Yield %. This places Samrat Pharmachem in the lower half of its industry. The industry median Dividend Yield % is 1.62. Samrat Pharmachem's value of 0.40% is 75.3% below this benchmark. Historically, Samrat Pharmachem's own Dividend Yield % has ranged from 0.09 to 0.51 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 1.62, Samrat Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Chemicals company?
The median Dividend Yield % among Chemicals companies is 1.62, based on 1,059 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Samrat Pharmachem's current Dividend Yield % of 0.40% is 75.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Samrat Pharmachem and its competitors. For the Chemicals industry, the median Dividend Yield % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samrat Pharmachem's current Dividend Yield % is 0.40%, which is 48% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹362.79, compared to a current price of ₹247.85 — trading 31.7% below its estimated fair value. The current Dividend Yield % is 0.40%, which is 48% above median its 10-year median of 0.27 and 75.3% below the Chemicals industry median of 1.62. Samrat Pharmachem's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current Dividend Yield % is 0.40% as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?
Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued.
The current stock price of ₹247.85 is trading 31.7% below its estimated GF Value™ of ₹362.79.
GuruFocus considers Samrat Pharmachem to be Significantly Undervalued.
Key valuation signals for BOM:530125:
Dividend Yield %: 0.40% (48% above median its 10-year median of 0.27)
GF Value™: ₹362.79 vs. price of ₹247.85 (31.7% below fair value)
Industry Position: 75.3% below the Chemicals median (#906 of 1059)
No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
63GF Score
Get the complete analysis for BOM:530125
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530125 has been successfully added to your 
